Hepascore predicts liver outcomes and all-cause mortality in long-term methotrexate users: A retrospective cohort study.

Zhengyi Wang Yi HuangHans NossentJonathan J ChanLeon A AdamsJohn JosephWendy ChengGeorge GarasGerry MacQuillanGary P Jeffrey

Published in: JGH open : an open access journal of gastroenterology and hepatology (2020)

This study demonstrated the potential importance of Hepascore monitoring in long-term MTX users. Patients with a Hepascore higher than 0.84 at any stage had increased mortality, but further studies are required to confirm this finding.

Keyphrases

high dose
cardiovascular events
risk factors
type diabetes
metabolic syndrome
adipose tissue
coronary artery disease
skeletal muscle
glycemic control